Back to User profile » Prof. Dr. Vincenzo Russo

Papers published by Prof. Dr. Vincenzo Russo:


Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report

Ianniciello A, Attena E, Carpinella G, Uccello A, Mauro C, Russo V

International Journal of General Medicine 2022, 15:6621-6626

Published Date: 16 August 2022

Non Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients Scheduled for Electrical Cardioversion: A Real-Life Propensity Score Matched Study

Rago A, Pezzullo E, Malvezzi Caracciolo d'Aquino M, Scognamiglio G, Caso VM, Martone F, Attena E, Parisi V, D'Onofrio A, Golino P, Nigro G, Russo V

Journal of Blood Medicine 2021, 12:413-420

Published Date: 4 June 2021

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study

Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi Snr A, Amitrano Snr M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P

Journal of Blood Medicine 2021, 12:69-75

Published Date: 11 February 2021

Blood Targets of Adjuvant Drugs Against COVID19

Di Micco P, Di Micco G, Russo V, Poggiano MR, Salzano C, Bosevski M, Imparato M, Fontanella L, Fontanella A

Journal of Blood Medicine 2020, 11:237-241

Published Date: 2 July 2020

Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation

Russo V, Paccone A, Rago A, Maddaloni V, Iafusco D, Proietti R, Atripaldi U, D'Onofrio A, Golino P, Nigro G

Journal of Blood Medicine 2020, 11:77-81

Published Date: 3 March 2020

Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials

Proietti R, Joza J, Arensi A, Levi M, Russo V, Tzikas A, Danna P, Sagone A, Viecca M, Essebag V

Medical Devices: Evidence and Research 2015, 8:103-114

Published Date: 29 January 2015